Navigation Links
Amylin Pharmaceuticals to Present New Data from Broad Diabetes and,Obesity Programs at ADA 2007

_blank" href= "http://www.amylin.com/">http://www.amylin.com.

This press release contains forward-looking statements about Amylin, which involve risks and uncertainties. Amylin's actual results could differ materially from those discussed herein due to a number of risks and uncertainties, including risks that BYETTA or SYMLIN, and the revenues Amylin generates from these products, may be affected by competition, unexpected new data, technical issues, or manufacturing and supply issues; risks that the results of pre-clinical studies or clinical trials may not be predictive of future results; risks that our clinical trials will not start or be completed when planned; risks that the FDA may not approve Amylin's regulatory submissions; and risks inherent in the drug development and commercialization process. Commercial and government reimbursement and pricing decisions and the pace of market acceptance may also affect the potential for BYETTA or SYMLIN. These and additional risks and uncertainties are described more fully

in Amylin's recently filed Form 10-Q. Amylin disclaims any obligation to update these forward-looking statements.

CONTACT: Alice Bahner Izzo of Amylin Pharmaceuticals, Inc.,+1-858-642-7272, cell, +1-858-232-9072, ; or RachelMartin of Edelman, +1-323-202-1031, cell, +1-323-373-5556,, for Amylin Pharmaceuticals, Inc. alice.izzo@amylin.com rachel.martin@edelman.com

Web site: http://www.amylin.com/http://scientificsessions.diabetes.org/

Ticker Symbol: (NASDAQ-NMS:AMLN)

Terms and conditions of use apply
Copyright © 2007 PR Newswire Association LLC. All rights reserved.
A United Business Media Company


'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:12/15/2014)... MEADOWS, N.Y. , Dec. 15, 2014 ... the SPL (Structured Product Labeling) markup language standard, content ... the understanding and skills to work with the standard. ... a series of three webinars on the benefits and ... three one-hour webinars will be facilitated by Howard ...
(Date:12/14/2014)...  ChartSpan, a consumer platform for patients managing healthcare ... medical app in the United States ... ChartSpan is an iPhone and iPad app ... send electronic healthcare records. The product was built by ... waiting for the healthcare system to deliver on the ...
(Date:12/13/2014)... Dec 12, 2014 Mindray Medical International Limited ... manufacturer and marketer of medical devices worldwide, today announced ... shareholders held in Hong Kong ... Mindray shareholders voted to re-elect incumbent directors Li Xiting ... Mindray,s shareholders did not re-elect Peter Wan ...
Breaking Medicine Technology:Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 2Data Conversion Laboratory Helping Life Sciences Content Producers Understand the Impact and Benefits of Structured Product Labeling 3ChartSpan Becomes The Most Downloaded Medical App in America 2ChartSpan Becomes The Most Downloaded Medical App in America 3Mindray Announced Shareholder Resolutions Post 2014 Annual General Meeting 2
... International Holdings , Inc. (NYSE Amex: BONE ... graft material and antimicrobial coatings for medical applications, has ... national investor relations firm, to develop and implement a ... strengthen its relationships with the investment community. ...
... 1, 2012   IntraOp Medical Corporation   (OTC: IOPD) ... dismissed the patent nullification case that IntraOp Medical had ... for a mobile IOERT linear accelerator with "straight through" ... slight clarification. IntraOp Medical,s European Patent ...
Cached Medicine Technology:Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 2Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 3Bacterin Retains Hayden IR to Develop Strategic Investor Relations Program 4IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 2IntraOp Medical wins Patent Defense Suit Protecting Their Intellectual Property 3
(Date:12/15/2014)... researchers have just published an important new report on ... mesothelioma. Surviving Mesothelioma has just posted an article on ... read it now. , Doctors at Harvard, MIT, ... Langone Medical Center performed complete genetic analyses on 22 ... to pinpoint the genes that are most likely to ...
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... 2014 SIMpalm, a leading mobile ... for iPhone for its client, which allows users to ... company, specialized in finding the right wine. At ... uses combined sensory, chemistry and wine information. All this ... “wine fingerprint.” Those wines that are close counterparts to ...
(Date:12/15/2014)... 2014 Health Dialog, a leading ... that it has received Patient Oriented Accreditation from ... its Disease Management (DM) Programs for asthma, congestive ... heart disease and diabetes. This marks the 12th ... Dialog’s Disease Management (DM) Programs, reaffirming Health Dialog’s ...
(Date:12/15/2014)... (HealthDay News) -- Expert pilots process visual information more ... make better decisions during landings, a new study shows. ... for pilots to master, and 36 percent of all ... during final approach and landing. Researchers monitored the ... experienced pilots while they were at the controls of ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Study Shows Why Expert Pilots Are Experts 2
... ... and provides healthy lifestyle message. , ... (Vocus) April 1, 2010 -- AthletiCo Physical Therapy and Occupational Therapy has signed a ... the 7th Inning Stretch Fan Cam for the 2010 through 2012 Major League Baseball (MLB) ...
... they know how cytomegalovirus continues to re-infect people , THURSDAY, ... how a virus known as cytomegalovirus (CMV), which infects up ... re-infects people again and again even though their immune systems ... always make people ill, but certain people, such as newborns ...
... with hepatitis C are fine for patients with the ... News) -- Every year, hundreds of kidneys are thrown ... but they could help many hepatitis C-infected patients waiting ... fact, since 1995, more than 3,500 kidneys infected with ...
... a cell wall and fuse with it could offer researchers ... of individual cells. Everything from signals generated as cells ... to medication could be monitored for up to a week, ... are so destructive they usually only allow a few hours ...
... of cancer cells to resist treatment with either targeted ... result from a transient state of reversible drug "tolerance." ... journal Cell and is receiving early online ... Center report finding small populations of drug-tolerant cells from ...
... Dr. Daniel D. Von Hoff, Physician-in-Chief for the Translational ... the American Society of Clinical Oncology (ASCO) for his cancer ... 2010 David A. Karnofsky Memorial Award and Lecture at ASCO,s ... Chicago. ASCO will present the award to Dr. Von ...
Cached Medicine News:Health News:AthletiCo Physical and Occupational Therapy and Chicago White Sox Partner for 7th Inning Stretch Fan Cam 2Health News:AthletiCo Physical and Occupational Therapy and Chicago White Sox Partner for 7th Inning Stretch Fan Cam 3Health News:Demystifying a Common, Persistent Virus 2Health News:Hundreds of Donor Kidneys Tossed Away Each Year 2Health News:Hundreds of Donor Kidneys Tossed Away Each Year 3Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 2Health News:Nanoscale 'stealth' probe slides into cell walls seamlessly, say Stanford engineers 3Health News:Treatment resistance in some cancer cells may be reversible 2Health News:TGen Physician-In-Chief Dr. Daniel D. Von Hoff wins ASCO award 2
Rheumatoid factor calibrator (Latex enhancedimmunoturbidimetric)...
Fructosamine Calibrator...
CRP high sensitivity calibrator series...
CRP Calibrator...
Medicine Products: